These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 291004

  • 21. (1-Beta-mercaptopropionic acid, 2-(3,5-dibromo-L-tyrosine))oxytocin, a potent inhibitor of oxytocin.
    Lundell EO, Ferger MF.
    J Med Chem; 1975 Oct; 18(10):1045-7. PubMed ID: 1159688
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Introduction of a cis-prolyl mimic in position 7 of the peptide hormone oxytocin does not result in antagonistic activity.
    Wittelsberger A, Patiny L, Slaninova J, Barberis C, Mutter M.
    J Med Chem; 2005 Oct 20; 48(21):6553-62. PubMed ID: 16220972
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Synthesis and some pharmacological properties of [4-threonine,7-sarcosine]oxytocin, a peptide with high oxytocic potency, and of [4-threonine,7-N-methylalanine]oxytocin.
    Grzonka Z, Lammek B, Gazis D, Schwartz IL.
    J Med Chem; 1983 Dec 20; 26(12):1786-7. PubMed ID: 6685771
    [Abstract] [Full Text] [Related]

  • 31. Oxytocin analogs with substitutions in postions 3 and 4.
    Roy J, Havran RT, Schwartz IL, Walter R.
    Int J Pept Protein Res; 1975 Dec 20; 7(2):171-8. PubMed ID: 1140889
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Deuterated oxytocins: the synthesis and biological properties of a crystalline analog of deamino-oxytocin deuterated in the 5-asparagine position.
    Blomquist AT, Rich DH, Carlson BA, Allen GA, Hruby VJ, Takashima H, Nangeroni LL, Glose P, Du Vigneaud V.
    Proc Natl Acad Sci U S A; 1969 Sep 20; 64(1):263-6. PubMed ID: 5263009
    [Abstract] [Full Text] [Related]

  • 34. Antagonists of oxytocin featuring replacement with modified beta-mercaptopropionic acids at position 1.
    Flouret G, Majewski T, Balaspiri L, Brieher W, Mahan K, Chaloin O, Wilson L, Slaninová J.
    J Pept Sci; 2002 Jul 20; 8(7):314-26. PubMed ID: 12148781
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Studies on pharmacological and biochemical properties of deamino-dicarba-[GLY-7]-oxytocin (Y-5350).
    Oka T, Nakanishi A, Okada T.
    Jpn J Pharmacol; 1975 Feb 20; 25(1):15-24. PubMed ID: 1152307
    [Abstract] [Full Text] [Related]

  • 37. [2-o-Iodotyrosine]-oxytocin and [2-o-methyltyrosine]-oxytocin: basic pharmacology and comments on their potential use in binding studies.
    Pliska V, Marbach P, Vasák J, Rudinger J.
    Experientia; 1977 Mar 15; 33(3):367-9. PubMed ID: 558109
    [Abstract] [Full Text] [Related]

  • 38. Dose-response behavior on the isolated rat uterus of oxytocin analogs with modifications at binding sites.
    Smith CW, Chan S, Walter R.
    J Pharmacol Exp Ther; 1977 Oct 15; 203(1):120-4. PubMed ID: 909047
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.